AdaptHealth CCO awarded 48,807 restricted shares

AdaptHealth Corp.’s Chief Commercial Officer Russell E. Schuster III reported an equity award of 48,807 shares of common stock on 01/30/2026.

Rhea-AI Filing Summary

AdaptHealth Corp.’s Chief Commercial Officer Russell E. Schuster III reported an equity award of 48,807 shares of common stock on 01/30/2026. The Form 4 shows the transaction coded as an acquisition at a reported price of $0.00 per share, indicating a stock-based grant.

A footnote explains these 48,807 shares are restricted stock units that will be settled in common stock upon vesting. After this award, Schuster beneficially owns 147,813 shares of AdaptHealth common stock in direct form.

Insider Trade Summary

Grant/Award: 48,807 shares

Grant/Award 1 txn

Insider Schuster III Russell E.

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	48,807	$0.00	$0.00

Holdings After Transaction: Common Stock — 147,813 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Russell Schuster?

AdaptHealth reported that Chief Commercial Officer Russell E. Schuster III acquired 48,807 shares of common stock on 01/30/2026. The transaction is coded as an acquisition at a reported price of $0.00 per share, reflecting a stock-based compensation grant.

How many AdaptHealth (AHCO) shares did Russell Schuster acquire on January 30, 2026?

On 01/30/2026, Russell E. Schuster III acquired 48,807 shares of AdaptHealth common stock. The Form 4 shows these as an acquired position at a reported price of $0.00 per share, consistent with a non-cash equity award rather than an open-market purchase.

What type of equity award did AdaptHealth (AHCO) grant its Chief Commercial Officer?

The award to the Chief Commercial Officer consists of restricted stock units covering 48,807 shares of common stock. A footnote clarifies these restricted stock units will be settled in AdaptHealth common stock upon vesting, aligning the executive’s compensation with future company performance.

How many AdaptHealth (AHCO) shares does Russell Schuster own after this Form 4 transaction?

Following the reported transaction, Russell E. Schuster III beneficially owns 147,813 shares of AdaptHealth common stock. This total reflects his direct holdings after receiving the 48,807-share restricted stock unit award reported on the Form 4 filing dated 01/30/2026.

Is Russell Schuster’s AdaptHealth (AHCO) ownership reported as direct or indirect in this Form 4?

The Form 4 lists Russell E. Schuster III’s 147,813 shares of AdaptHealth common stock as directly owned. The ownership form is marked as “D” for direct, with no separate nature-of-ownership description indicating an intermediary entity or indirect holding structure.

What does the restricted stock unit footnote in the AdaptHealth (AHCO) Form 4 mean?

The footnote explains that the 48,807 reported shares represent restricted stock units, not immediately transferable stock. These units will be settled in AdaptHealth common stock upon vesting, meaning Schuster’s ability to receive and dispose of the underlying shares depends on satisfying vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 08:23 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schuster III Russell E.

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		48,807(1)	A	$0	147,813	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Russell Schuster	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.